Perrigo | PRGO - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
AbbVie USD 5.23B 400M 2025-12
Abbott USD 8.52B 1.01B 2025-12
Bayer EUR 5.9B 1.34B 2025-09
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Coherus Biosciences USD 88.88M 14.47M 2025-12
Corcept Therapeutics USD 120.49M 4.64M 2025-12
Dr.Reddys Laboratories INR 18.66B 8.75B 2025-12
Eli Lilly USD 7.27B 2.52B 2025-12
J&J USD 19.71B 1.48B 2025-12
Merck USD 18.17B 10.16B 2025-09
Nestle CHF 4.65B 904M 2025-06
Pacira USD 158.54M 10.96M 2025-12
Perrigo USD 432.1M 22.1M 2025-09
Pfizer USD 1.34B 295M 2025-09
Phibro Animal Health USD 55.49M 17.28M 2025-12
Prestige Brands USD 62.37M 56.73M 2025-12
Reckitt Benckiser GBP 880M 106M 2024-12
Sanofi EUR 7.66B 1.25B 2025-12
Supernus Pharmaceuticals USD 151.37M 6.66M 2025-09
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12
Xeris Pharmaceuticals USD 91.6M 32.32M 2025-09
Zoetis USD 2.08B 649M 2025-09